NZ598249A - Purification of vwf for increased removal of non-lipid enveloped viruses - Google Patents

Purification of vwf for increased removal of non-lipid enveloped viruses

Info

Publication number
NZ598249A
NZ598249A NZ598249A NZ59824910A NZ598249A NZ 598249 A NZ598249 A NZ 598249A NZ 598249 A NZ598249 A NZ 598249A NZ 59824910 A NZ59824910 A NZ 59824910A NZ 598249 A NZ598249 A NZ 598249A
Authority
NZ
New Zealand
Prior art keywords
protein
exchange resin
cation exchange
solution
wash buffer
Prior art date
Application number
NZ598249A
Other languages
English (en)
Inventor
Artur Mitterer
Meinhard Hasslacher
Christa Mayer
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43063204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ598249(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of NZ598249A publication Critical patent/NZ598249A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ598249A 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses NZ598249A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23557009P 2009-08-20 2009-08-20
PCT/US2010/046180 WO2011022657A1 (en) 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses

Publications (1)

Publication Number Publication Date
NZ598249A true NZ598249A (en) 2014-04-30

Family

ID=43063204

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ598249A NZ598249A (en) 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses

Country Status (18)

Country Link
US (1) US9315560B2 (enExample)
EP (1) EP2467399B2 (enExample)
JP (1) JP5838159B2 (enExample)
KR (1) KR101894600B1 (enExample)
CN (2) CN106008697B (enExample)
AU (1) AU2010284116B9 (enExample)
BR (1) BR112012003802B1 (enExample)
CA (1) CA2771232A1 (enExample)
DK (1) DK2467399T3 (enExample)
ES (1) ES2562256T5 (enExample)
HU (1) HUE026907T2 (enExample)
IN (1) IN2012DN01849A (enExample)
MX (1) MX2012002129A (enExample)
NZ (1) NZ598249A (enExample)
PL (1) PL2467399T3 (enExample)
PT (1) PT2467399E (enExample)
SG (2) SG10201408106WA (enExample)
WO (1) WO2011022657A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
KR101772674B1 (ko) 2008-10-21 2017-09-01 박스알타 인코퍼레이티드 동결건조된 재조합 vwf 제제
SG11201408490PA (en) * 2012-06-21 2015-01-29 Baxter Int Virus filtration of cell culture media
US9902942B2 (en) 2013-02-22 2018-02-27 Agency For Science, Technology And Research Chromatographic purification of virus preparations with negatively charged particles
DK3152230T3 (da) * 2014-06-06 2019-11-11 Octapharma Ag Præparat omfattende faktor viii og von willebrand-faktor-peptider
DK3158055T3 (da) 2014-06-13 2019-10-14 Csl Ltd Forbedret produktion af recombinant von willebrand-faktor i en bioreaktor
KR20250088663A (ko) 2017-08-23 2025-06-17 체에스엘 베링 게엠베하 폰 빌레브란트 인자의 바이러스 여과 방법
EP3768697A1 (en) 2018-03-21 2021-01-27 Baxalta Incorporated Separation of vwf and vwf propeptide by chromatographic methods
CA3244889A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd FLUID TRANSFER STATION IN A ROBOTIC PHARMACEUTICAL PREPARATION SYSTEM

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) * 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
EP0218692A4 (en) 1985-04-11 1988-03-22 Childrens Medical Center VON WILLEBRAND FACTOR.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
AT406373B (de) * 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
US6531577B1 (en) 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
ES2261589T3 (es) * 1998-05-06 2006-11-16 Genentech, Inc. Composicion de anticuerpos anti-her2.
AU2005322067B8 (en) * 2004-12-27 2012-07-26 Takeda Pharmaceutical Company Limited Polymer-von Willebrand factor-conjugates

Also Published As

Publication number Publication date
DK2467399T3 (en) 2017-01-23
US20110092681A1 (en) 2011-04-21
CN106008697A (zh) 2016-10-12
BR112012003802A2 (pt) 2016-11-22
CN106008697B (zh) 2020-08-04
ES2562256T3 (es) 2016-03-03
AU2010284116B2 (en) 2015-02-12
BR112012003802B1 (pt) 2022-10-25
EP2467399B1 (en) 2015-11-11
IN2012DN01849A (enExample) 2015-08-21
EP2467399B2 (en) 2023-02-01
SG178478A1 (en) 2012-04-27
CA2771232A1 (en) 2011-02-24
AU2010284116B9 (en) 2015-03-26
PL2467399T3 (pl) 2016-05-31
JP2013502434A (ja) 2013-01-24
US9315560B2 (en) 2016-04-19
KR101894600B1 (ko) 2018-09-03
ES2562256T5 (es) 2023-07-20
HUE026907T2 (en) 2016-07-28
WO2011022657A1 (en) 2011-02-24
MX2012002129A (es) 2012-06-08
PT2467399E (pt) 2016-03-18
CN102482341A (zh) 2012-05-30
EP2467399A1 (en) 2012-06-27
JP5838159B2 (ja) 2015-12-24
AU2010284116A1 (en) 2012-03-08
KR20120065342A (ko) 2012-06-20
SG10201408106WA (en) 2015-01-29

Similar Documents

Publication Publication Date Title
NZ598249A (en) Purification of vwf for increased removal of non-lipid enveloped viruses
HRP20192303T1 (hr) Postupak za pročišćavanje rekombinantnog adamts13 i drugih proteina i njihovih pripravaka
RU2014111820A (ru) Способы элиминации вируса
CO6331367A2 (es) Composiciones y metodos que comprenden variantes de celulasa con afinidad reducida para materiales no celulosicos
EP3575389A3 (en) Consumer products with protease variants
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
RU2011102437A (ru) Способ очистки фактора свертывания крови viii
SG10201908027QA (en) Use of alkaline washes during chromatography to remove impurities
ATE435906T1 (de) Verfahren zur reinigung von viren
MX166885B (es) Metodos de purificacion y reactivacion de proteinas heterologas precipitadas
JP2013500711A5 (enExample)
CN103382637B (zh) 胶原蛋白提高超细纤维合成革基布卫生性能的改性方法
AR071969A1 (es) Proteasa especifica de prolina identificada en el hongo penicillium chrysogenum
EA201100071A1 (ru) Новые композиции и способы
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
EA201100072A1 (ru) Новые композиции и способы
WO2009117256A3 (en) Conveyor warewasher and method for operating a conveyor warewasher
NZ594212A (en) Method for production of lactoferrin
NZ597809A (en) Method to improve virus removal in protein purification
RU2013118323A (ru) Способ получения фибриногена
RU2016104651A (ru) Устойчивые к протеазам пептидные лиганды
RU2017101727A (ru) Способы и реагенты для очистки белков
JP2014507368A5 (enExample)
NZ603289A (en) Purification method for divalent cation binding proteins on anion exchange resin
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 20 AUG 2017 BY CULLENS

Effective date: 20140819

ASS Change of ownership

Owner name: BAXALTA INC, US

Effective date: 20160414

Owner name: BAXALTA GMBH, CH

Effective date: 20160414

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2018 BY COMPUTER PACKAGES INC

Effective date: 20170801

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2019 BY ANAQUA SERVICES

Effective date: 20180719

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2020 BY ANAQUA SERVICES

Effective date: 20190722

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2021 BY ANAQUA SERVICES

Effective date: 20200721

ASS Change of ownership

Owner name: TAKEDA PHARMACEUTICAL COMPANY, JP

Effective date: 20210621

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2022 BY ANAQUA SERVICES

Effective date: 20210720

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2023 BY ANAQUA SERVICES

Effective date: 20220721

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2024 BY ANAQUA SERVICES

Effective date: 20230720

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2025 BY ANAQUA SERVICES

Effective date: 20240723

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 AUG 2026 BY ANAQUA SERVICES

Effective date: 20250724